BPC-157 10mg
Body Protection Compound-157 — 15-amino acid synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) One of the most studied research peptides — over 100 published preclinical papers CAS 137525-51-0 For in vitro research only
For laboratory research use only. Not for human or veterinary consumption. SKU BC10.
Product details.
Specifications
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| One-Letter Code | GEPPPGKPADDAGLV |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.53 g/mol |
| CAS Number | 137525-51-0 |
| PubChem CID | 108101 |
| Form | Lyophilized powder |
| Quantity | 10mg per vial |
Connective tissue research
Chang et al. documented tendon outgrowth, cell survival, and migration linked to F-actin formation and FAK-paxillin pathway activation in tendon fibroblast cultures (J Applied Physiology, 2011; PubMed 21030672).
Gastrointestinal research
This is where BPC-157 was first characterized. Sikiric et al. coined the “stable gastric pentadecapeptide” label after documenting cytoprotective properties across gastric lesion, IBD, and intestinal anastomosis models (Curr Pharm Design, 2018; PubMed 29998800).
Nitric oxide pathways
Research has examined BPC-157 in the context of VEGFR2-Akt-eNOS signaling and experimental angiogenesis. Huang et al. documented ERK1/2 phosphorylation and downstream transcription factor activation in vascular models (Drug Design, Development and Therapy, 2015; DOI 10.2147/DDDT.S82030).
Neuroprotective research
Vukojevic et al. reviewed BPC-157 interactions within CNS experimental models including traumatic brain injury systems (Neural Regeneration Research, 2022; PubMed 34380872).
BPC-157 vs TB-500
Both appear in tissue recovery protocols, but the mechanisms are distinct. BPC-157: GI integrity, connective tissue, NO pathway modulation. TB-500: actin regulation, cell migration, cardiac tissue, blood vessel formation. Complementary, not redundant. Available individually or as a BPC-TB blend.
Frequently paired with
- TB-500 10mg — Available as BPC-TB Blend.
- GHK-Cu 50mg — Available in Glow 50/10/10.
- LL-37 10mg — Immune pathway research.
Storage
- Lyophilized: -20°C
- Reconstituted: 2-8°C, use within 30 days
- Protection: Shield from light and moisture; avoid freeze-thaw cycles
References
- Chang CH, et al. J Applied Physiology. 2011;110(3):774-780. PubMed 21030672
- Seiwerth S, et al. Curr Pharm Design. 2018;24(18):1972-1989. PubMed 29998800
- Sikiric P, et al. Curr Pharm Design. 2014;20(7):1126-1135. PubMed 23755727
- Vukojevic J, et al. Neural Regen Res. 2022;17(3):482-487. PubMed 34380872
- Huang T, et al. Drug Design Dev Ther. 2015. DOI 10.2147/DDDT.S82030
- He L, et al. Front Pharmacol. 2022;13:1026182.
FAQ
What is BPC-157?
A 15-amino-acid synthetic peptide originally identified from human gastric juice. Over 100 preclinical studies across connective tissue, GI, vascular, and neurological models.
BPC-157 vs TB-500?
Different mechanisms. BPC-157: gastrointestinal integrity, connective tissue, nitric oxide pathways. TB-500: actin dynamics, cell migration, cardiac tissue. Complementary, not interchangeable.
Is BPC-157 approved for human use?
No. It is a research compound not evaluated or approved by the FDA. Heritage Labs USA products are strictly for laboratory research. For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.
Technical reference adapted from the original Heritage Labs USA product listing. This description is not a certificate of analysis or evidence of testing for inventory supplied by this store.
